Suchergebnisse - "Rimassa, Lorenza"

PubPharm (18)

1

The Immune Landscape in a Long-Term Survival Pancreatic Adenocarcinoma Patient Highly Responsive to a Multidisciplinary Approach With Chemo-Radio Treatments

enthalten in: Pancreas | 2021

von Barbagallo, M. | Ciprani, D. | Rimassa, L. | +5

2

Synaptophysin expression in V600EBRAF-mutated advanced colorectal cancers identifies a new subgroup of tumours with worse prognosis

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Fassan, M. | Milione, M. | Maddalena, G. | +28

3

FIGHT-302 : first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with FGFR2 rearrangements

enthalten in: Future oncology (London, England) | 2020

von Bekaii-Saab, T. | Valle, J. | Van Cutsem, E. | +15

4

The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer : results from a pooled-analysis of the Valentino and TRIBE first-line trials

enthalten in: British journal of cancer | 2020

von Fucà, G. | Guarini, V. | Antoniotti, C. | +22

5

Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with panitumumab-based first-line treatment strategy : A pre-specified secondary analysis of the Valentino study

enthalten in: European journal of cancer (Oxford, England : 1990) | 2020

von Raimondi, A. | Di Maio, M. | Morano, F. | +24

6

Capecitabine and Temozolomide versus FOLFIRI in RAS-Mutated, MGMT-Methylated Metastatic Colorectal Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2020

von Pietrantonio, F. | Lobefaro, R. | Antista, M. | +28

CommentIn: Clin Cancer Res. 2020 Jul 1;26(13):3493-3494. - PMID 32611627

7

CK7 and consensus molecular subtypes as major prognosticators in V600EBRAF mutated metastatic colorectal cancer

enthalten in: British journal of cancer | 2019

von Loupakis, F. | Biason, P. | Prete, A. | +29

8

A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer : the 'BRAF BeCool' study

enthalten in: European journal of cancer (Oxford, England : 1990) | 2019

von Loupakis, F. | Intini, R. | Cremolini, C. | +41

9

Characterisation of the immune-related transcriptome in resected biliary tract cancers

enthalten in: European journal of cancer (Oxford, England : 1990) | 2017

von Ghidini, M. | Cascione, L. | Carotenuto, P. | +17

10

Assessment of HER2 status in patients with gastroesophageal adenocarcinoma treated with epirubicin-based chemotherapy : heterogeneity-related issues and prognostic implications

enthalten in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | 2017

von Personeni, N. | Baretti, M. | Bozzarelli, S. | +9